RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Showing results 1 to 20 of 138.

Article

Relationship between body fat and BMI in a US hispanic population-based cohort study: Results from HCHS/SOL

July 01, 2016
Article

A research framework for cognitive aging and Alzheimer's disease among diverse US Latinos: Design and implementation of the Hispanic Community Health Study/Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)

December 01, 2019
Article

Gut microbial factors implicated in disease progression and treatment response in pediatric ulcerative colitis

May 01, 2018
Article

Cost effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for refractory urgency urinary incontinence: Results of the ROSETTA randomized trial

May 01, 2020
Article

Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trial

December 01, 2005
News Release

RTI International makes significant contributions to first-ever positive clinical trial for treating rare hereditary blood disorder

September 18, 2024
Article

Sleep duration and neurocognitive function in the Hispanic Community Health Study/Study of Latinos

October 01, 2016
Article

The treatment of chronic depression, part 2: A double-blind, randomized trial of sertraline and imipramine

November 01, 1998
Article

Time to all-cause treatment discontinuation as the primary outcome in the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia study

May 01, 2011
Article

Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial

July 01, 2008
Article

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1

August 01, 2008
Article

Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo

August 01, 2002
Article

Association of dispositional optimism with Life's Simple 7's Cardiovascular Health Index: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Sociocultural Ancillary Study (SCAS)

March 05, 2018
Article

American College of Cardiology/American Heart Association (ACC/AHA) class I guidelines for the treatment of cholesterol to reduce atherosclerotic cardiovascular risk: Implications for US Hispanics/Latinos based on findings from the Hispanic Community Heal

May 11, 2017
Article

The treatment of chronic depression, part 3: Psychosocial functioning before and after treatment with sertraline or imipramine

November 01, 1998
Article

Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument

July 26, 2022
Article

Reply by authors: "Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial"

May 11, 2020
Article

Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial

January 01, 2003
Article

Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia

January 01, 2011
Article

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

December 01, 2005